Comparison of Proliferation Markers Ki-67 and Phosphohistone-H3 (pHH3) in Ductal Carcinoma In Situ of Breast

被引：0
|
作者：
Chang, O. H. [1 ]
Kilgore, M. R. [1 ]
Schmidt, R. A. [1 ]
Swanson, P. E. [1 ]
Rendi, M. H. [1 ]
机构：
[1] Univ Washington, Med Ctr, Seattle, WA 98195 USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2126
引用
收藏
页码：520A / 520A
页数：1
相关论文
共 50 条
  • [1] Comparison of Proliferation Markers Ki-67 and Phosphohistone-H3 (pHH3) in Ductal Carcinoma In Situ of Breast
    Chang, O. H.
    Kilgore, M. R.
    Schmidt, R. A.
    Swanson, P. E.
    Rendi, M. H.
    MODERN PATHOLOGY, 2014, 27 : 520A - 520A
  • [2] Comparison of Proliferation Markers Ki67 and Phosphohistone-H3 (pHH3) in Breast Ductal Carcinoma In Situ
    Bosch, Dustin E.
    Kilgore, Mark R.
    Schmidt, Rodney A.
    Swanson, Paul E.
    Rendi, Mara H.
    Chang, Oliver H.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (08) : 543 - 547
  • [3] The Utility of Phosphohistone-H3 Immunohistochemistry (PHH3) in Pheochromocytomas
    Portillo, S. Canete
    Theriault, A.
    Rosas, F.
    Magi-Galluzzi, C.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S43 - S44
  • [4] Prognostic impact of proliferation markers Ki-67, PHH3 and mitotic count in breast carcinomas
    Knutsvik, G.
    Stefansson, I. M.
    Collett, K.
    Akslen, L. A.
    VIRCHOWS ARCHIV, 2012, 461 : S5 - S5
  • [5] Comparison of PHH3, Ki-67 and H&E Mitotic Count in Invasive Breast Carcinoma
    Woo, Jennifer
    Moatamed, Neda
    Sullivan, Peggy
    Lu, David
    Apple, Sophia
    MODERN PATHOLOGY, 2015, 28 : 74A - 74A
  • [6] Comparison of PHH3, Ki-67 and H&E Mitotic Count in Invasive Breast Carcinoma
    Woo, Jennifer
    Moatamed, Neda
    Sullivan, Peggy
    Lu, David
    Apple, Sophia
    LABORATORY INVESTIGATION, 2015, 95 : 74A - 74A
  • [7] Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices
    Iwasaki, Takeshi
    Matsushita, Michiko
    Nonaka, Daisuke
    Kato, Masako
    Nagata, Keiko
    Murakami, Ichiro
    Hayashi, Kazuhiko
    PATHOLOGY INTERNATIONAL, 2015, 65 (08) : 404 - 409
  • [8] The Utility of Phosphohistone-H3 (PHH3), Ki-67, and p16 in Characterizing Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP)
    Xing, Deyin
    Tracht, Jessica
    Ross, John
    Conner, Michael
    Wei, Shi
    MODERN PATHOLOGY, 2015, 28 : 316A - 316A
  • [9] The Utility of Phosphohistone-H3 (PHH3), Ki-67, and p16 in Characterizing Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP)
    Xing, Deyin
    Tracht, Jessica
    Ross, John
    Conner, Michael
    Wei, Shi
    LABORATORY INVESTIGATION, 2015, 95 : 316A - 316A
  • [10] The Utility of Phosphohistone-H3 (PHH3) Immunohistochemistry as an Adjunct in Grading Follicular Lymphoma
    Khieu, Michelle
    Broadwater, Devin R.
    Coviello, Jean
    Lynch, David
    Hall, Jordan
    LABORATORY INVESTIGATION, 2018, 98 : 528 - 528
12345